CJC-1295 NO DAC Dosage, Protocol, and GH Optimization Guide (Mod GRF 1–29)

CJC-1295 NO DAC (Mod GRF 1–29)

CJC-1295 NO DAC (Modified GRF 1–29) is a short-acting GHRH analog that stimulates natural, pulsatile growth hormone release. Unlike DAC versions or exogenous HGH, it preserves physiologic hormone rhythms and feedback mechanisms.

How CJC-1295 NO DAC Works

GHRH Signal → Pituitary Activation → GH Pulse ↑ → IGF-1 ↑ → Recovery + Fat Loss ↑

CJC-1295 NO DAC binds to GHRH receptors in the pituitary, triggering natural GH pulses. Its short half-life (~30 minutes) mimics the body’s normal secretion pattern, making it ideal for physiologic hormone optimization.

CJC-1295 NO DAC Protocol

Weeks 1–2

Dose100 mcg

Units6 units (0.06 mL)

Weeks 3–4

Dose150 mcg

Units9 units (0.09 mL)

Weeks 5–6

Dose200 mcg

Units12 units (0.12 mL)

Weeks 7–12

Dose250–300 mcg

Units15–18 units

Frequency: Once daily (advanced: 2x daily)
Timing: Bedtime (fasted ≥2 hours)
Cycle Length: 8–12 weeks (extend to 16 weeks)

Clinical vs Real-World Use

• Short half-life requires consistent timing
• Pulsatile GH release mimics natural physiology
• Often stacked with GHRPs (Ipamorelin) in research

When & Where to Inject

• Subcutaneous injection
• Abdomen, thigh, or upper arm
• Administer before bed (fasted)
• Optional: split AM + PM dosing for advanced users

Reconstitution & Dosing (5 mg Vial)

Vial 5 mg

Water 3.0 mL bacteriostatic

Concentration 1.67 mg/mL

Conversion 1 unit = 16.7 mcg

Reconstitution Steps

Draw 3.0 mL bacteriostatic water

Inject slowly down vial wall

Gently swirl (do not shake)

Refrigerate immediately

Storage

Lyophilized: 2–8°C or freeze ≤−20°C

Reconstituted: 2–8°C refrigerated

Use Window

Use within 7–14 days

Monitoring During Use

• IGF-1 levels (primary marker)
• Sleep quality
• Recovery and soreness
• Body composition changes

Benefits

• Stimulates natural GH release
• Increases IGF-1 levels
• Improves recovery and sleep
• Supports fat loss and lean mass
• Maintains physiologic hormone balance

Potential Side Effects

• Injection site irritation
• Mild flushing
• Headache (rare)
• Temporary water retention (mild)

Stacking Strategies

• GH Optimization: CJC-1295 NO DAC + Ipamorelin
• Fat Loss: CJC-1295 + AOD-9604
• Recovery: CJC-1295 + BPC-157

Important Notes

• Short half-life requires consistent dosing
• Works best fasted
• Requires functional pituitary
• More physiologic than exogenous GH

Important Disclaimer

CJC-1295 NO DAC is not FDA-approved. This content is for educational purposes only.

Peptide Directory →